Academic Journals Database
Disseminating quality controlled scientific knowledge

MORBIDITY AND MORTALITY IN MULTIORGAN RESECTION FOR GASTRIC AND COLO-RECTAL CANCER

ADD TO MY LIST
 
Author(s): A. Bartoș | Dana Iancu | L. Mocanu | Teodora Mocanu | Raluca Bodea | F. Zaharie | Andra Andreescu | C. Iancu

Journal: Jurnalul de Chirurgie
ISSN 1584-9341

Volume: 6;
Issue: 4;
Start page: 438;
Date: 2010;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: ABDOMINAL NEOPLASIA | MULTIORGAN RESECTION | MORBIDITY | MORTALITY

ABSTRACT
Introduction: The multiorgan resection for oncological pathology is continuing to be an issue because of the important question that is raised: benefits versus high morbidity, does it worth it? Material and method: 158 patients admitted in Clinica Chirurgie III , Cluj-Napoca were included in the study; all of them suffered multiorgan resections for oncological pathology. The study is a retrospective one, betwen year 2006 and 2009; it's goal is to discover the local and general postoperative complications. In this paper we compare the morbidity and mortality in multiorgan resection for colon and gastric cancer stage T4 with the one′s from limited resection (colon or stomach). Results: Our study indicated a higher rate of postoperative complications and deaths when refering to multiorgan resections. Postoperative complications: 13,13% vs 27,27% (gastric cancer), and 14,18% vs 25% (colo-rectal cancer). Postoperative deaths: 5,34% vs 9,09% (gastric cancer), and 2,73% vs 9% (colo-rectal cancer). Conclusions: The multiorgan resection for intraabdominal cancers stage T4 is a feasible solution but only in carefully selected cases; this way the morbidity and mortality would be acceptable.
Why do you need a reservation system?      Save time & money - Smart Internet Solutions